Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next?
Scienture’s unprecedented Oct. 23 rally was driven by the commercial rollout of Arbli, its first revenue-generating product. The company’s press release on Oct. 23 confirmed that it began sales and shipped first